Fulgent Genetics (STU:7F0) Total Stockholders Equity : €1,042.6 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Fulgent Genetics Total Stockholders Equity?

Fulgent Genetics's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €1,042.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Fulgent Genetics's Book Value per Share for the quarter that ended in Mar. 2025 was €34.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Fulgent Genetics's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.01.

Fulgent Genetics Total Stockholders Equity Historical Data

The historical data trend for Fulgent Genetics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Total Stockholders Equity Chart

Fulgent Genetics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

468.04

1,025.49

1,195.75

1,041.81

1,082.23

Fulgent Genetics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,039.55	1,052.14	1,025.74	1,082.23	1,042.64

Fulgent Genetics (STU:7F0) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Fulgent Genetics's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1042.64	-	0)	/	30.621
	=	34.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Fulgent Genetics's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.671	+	5.412)	/	1042.64
	=	0.01

Fulgent Genetics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (STU:7F0) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

FLGT:USA FLGT:Mexico 7F0:Germany

Address

4399 Santa Anita Avenue, El Monte, CA, USA, 91731

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Headlines

No Headlines